Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.1

(5.58%)

FLWS

$3.57

(0.28%)

ACCO

$4.27

(1.43%)

ARLP

$23.99

(-2%)

AUIAF

$0.13

(-5.29%)

AZZ

$152.49

(-2.65%)

BTBT

$1.83

(-8.04%)

BTM

$0.49

(0%)

CVKD

$3.02

(-0.98%)

LCE:CA

$0.27

(1.89%)

COCP

$1.03

(0.98%)

CDRO

$9.57

(-0.67%)

CVGI

$4.62

(2.44%)

LODE

$4.22

(-2.76%)

CMTL

$2.04

(-1.45%)

CNDT

$1.28

(-3.03%)

CXW

$30.29

(-1.56%)

CMLS

$0.01

(0%)

DRCT

$2.64

(-0.38%)

DLHC

$5.3

(0.76%)

SSP

$2.85

(-1.72%)

ELDN

$3.88

(2.65%)

EVC

$13.48

(12.05%)

EDRY

$22.14

(0.59%)

ESEA

$66.5

(0.23%)

FAT

$0.16

(0%)

RAIL

$9.76

(-4.31%)

GDEV

$12.14

(1.17%)

GOVX

$1.28

(-3.03%)

GOCO

$0

(0%)

GHM

$119.82

(-1.51%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

$1.72

(-0.23%)

III

$4.09

(-2.62%)

IPOOF

$10.26

(1.12%)

KELYA

$12.85

(0.94%)

KTOS

$46.95

(-0.55%)

LUCK

$7.77

(-1.52%)

MAIA

$1.48

(4.96%)

MGROF

$0.28

(-4.7%)

NTRB

$3.21

(4.9%)

OCGN

$1.67

(11.33%)

PERF

$1.65

(-0.6%)

QMCI

$0.15

(0%)

RGP

$4.37

(7.37%)

SGA

$8.74

(0.58%)

SHWZ

$0

(0%)

SHIP

$13.61

(-2.51%)

SLQT

$0.8

(-3.22%)

SKYX

$1.01

(6.74%)

SNAL

$0.64

(4.34%)

GEO

$29.46

(-2.96%)

ODP

$28

(0%)

TNXP

$12.75

(-3.56%)

TSQ

$6.96

(1.9%)

TZOO

$11.59

(3.85%)

UNCY

$7.7

(7.99%)

VVX

$71.03

(-2%)

VNCE

$7.79

(0.39%)

XELB

$1.77

(-1.12%)

ZOMDF

$0.1

(5.58%)

FLWS

$3.57

(0.28%)

channelchek-in

‌

6/29/2026

Zymeworks Moves to Acquire Theravance Biopharma in $929 Million Deal

Vancouver-based Zymeworks (Nasdaq: ZYME) announced this morning it has signed a definitive agreement to acquire Theravance Biopharma (Nasdaq: TBPH) for $17.00 per share in cash, a deal valued at roughly $929 million. The transaction adds YUPELRI® (revefenacin), the only nebulized once-daily LAMA approved for COPD maintenance therapy, to Zymeworks’ growing portfolio of partnered commercial assets.

0

3 min read

News

6/29/2026

Release – NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS

7 min read

‌

Release – NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS

6/29/2026

Release – Star Equity Holdings Added to the Russell Microcap® Index

3 min read

‌

Release – Star Equity Holdings Added to the Russell Microcap® Index

6/29/2026

Release – Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

6 min read

‌

Release – Alliance Authentic Expands Its Preservation Platform Across Collecting, From Vinyl to Funko to Handmade by Robots

6/29/2026

Release – FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes

2 min read

‌

Release – FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes

Research Reports

V2X (VVX) – A Major Recompete Win(T3 Defense (DFNS) – Operating at the Critical Chokepoints of the Defense Industrial BaseD(AZZ (AZZ) – AZZ to Report First Quarter FY 2027 Results on July 8; Quarterly Cash Dividend Increased 20%(DLH Holdings (DLHC) – Navy ContractH(

Video Content

‌

First Phosphate Corp.

First Phosphate Corp.

C-Suite Interview

6/22/2026

‌

DHI Group Inc.

DHI Group Inc.

Conference Presentation

6/4/2026

‌

Ocugen

Ocugen

Conference Presentation

6/4/2026

‌

T3 Defense Inc.

T3 Defense Inc.

Conference Presentation

6/4/2026

Movers

Symbol	Change
SDOT	67.13%
NNBR	31.16%
ASTC	30.83%
OUST	28.68%
SLS	24.7%